The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 741 Metabolic Health articles
As new weight-loss medications enter the UAE market, patients are questioning insurance coverage. We break down the realities of policy, medical necessity, and the future of metabolic health.
Rebel Wilson's transformation is more than a celebrity headline; it's a masterclass in metabolic health. Discover the role of GLP-1s, the science of consistency, and why moderation beats intensity.
The FDA is evaluating the regulation of specific peptides amid growing demand. We break down the science, the risks, and the clinical implications.
The federal government has extended its commitment to fund GLP-1 obesity medications through 2027, shifting away from private insurer mandates to protect seniors from premium hikes.
As GLP-1 medications like Ozempic and Wegovy change dietary habits, U.S. farmers are pivoting to pulse crops to meet the surging demand for high-protein foods.
A new study in Obesity Pillars suggests that while GLP-1 drugs aid weight loss, they may impact sexual desire through brain chemistry. Here is what you need to know.
A new lifetime economic analysis suggests tirzepatide may offer superior long-term value and clinical outcomes compared to semaglutide for obesity management.
Is your GLP-1 medication affecting your mood? Discover the science behind anhedonia, the 'Ozempic personality' phenomenon, and what experts say about dopamine and metabolic health.
A leading gynaecologist at Aston Medical School is probing whether GLP-1 drugs like Ozempic and Mounjaro could transform care for women with PCOS. With a £60,000 NHS grant, Dr Shagaf Bakour aims to evaluate their effects on metabolic health and fertility. This investigation highlights hope for better treatment pathways amid rising interest in these weight loss jabs.
